FDA Seeks Public Comments on Increasing Transparency With Regulated Industry
(FDA: Washington) -- As part of the final phase of its transparency initiative, the U.S. Food and Drug Administration (FDA) is seeking comment from the public and other interested stakeholders on how the agency can increase transparency in its interactions with regulated industry.